Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This correspondence discusses different approaches to managing patients on the anti-platelet medication Plavix and reports no new clinical results.

This article reviews online discussions on managing psoriasis in patients considering hair restoration surgery, and it reports no new clinical findings.

This article recounts a conversation about a patient's inquiry on using Rogaine for hair thinning, providing no new research findings.

This report warns that the Total Body Mega Formula nutritional supplement may cause selenium toxicity leading to significant hair loss.

This study utilized a fluorescence probe to evaluate cysteine formation on hair fibers, finding that optimal fluorescence emission occurred at pH 4.5.

This review discusses the controversial non-inflammatory alopecia known as alopecia X, highlighting its unknown etiology and the variable effectiveness of various proposed treatments, but reports no new results.

This study found that while the new cytopurine/pentadecanoic glyceride topical solution significantly improved total hair and daily shed hair counts in AGA patients, it did not show significant differences compared to placebo in other measures.

This study identified a new genotype, V281+I172N/V281L, linked to non-classical 21-hydroxylase deficiency, suggesting it should be considered in genetic panels for the condition.

This study found that the enzyme encoded by Dgat1 acts as a retinol acyltransferase in murine epidermis, protecting against retinoid toxicity and alopecia by preventing retinol accumulation.

This review addresses concerns about finasteride and high-grade prostate cancers but reports no new clinical results.

This study found that CPA-loaded nanoparticles, particularly SLN formulations, increased CPA epidermal penetration compared to a conventional cream and may reduce side effects in treating androgen-dependent conditions.

This case report describes a 57-year-old woman's virilizing adrenal tumor effectively treated with the antiandrogen cyproterone acetate, which led to symptom reversal and tumor resolution.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Lowering the dose of cyclosporin caused hair loss that didn't improve even when the dose was increased again.

This study observed that cytokeratin 19 expression in cutaneous carcinomas correlates with the grade of squamous cell carcinomas, with more expression in higher-grade SCCs.

This study found that cyclosporin A stimulated hair growth in mouse vibrissae follicles by promoting cell proliferation, reducing apoptosis, and altering the expression of certain growth factor mRNAs.

This study found that oral cyclosporine combination therapy led to new hair growth in 71% of patients with severe and refractory alopecia areata, though mild and transient side effects were common.

This study demonstrated that cyclosporin A upregulated mRNA expression of HGF and VEGF in cultured mouse vibrissa follicles.

This study concluded that a combination of millet seed extract, L-cystine, and calcium pantothenate may improve anagen hair rate in women with androgenetic alopecia over six months.

Cyclosporine starts hair growth faster, while minoxidil makes it last longer.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

This study found that AtT-20 pituitary cells with higher cAMP-dependent kinase activity had larger calcium currents and significantly increased beta-endorphin release compared to cells with lower kinase activity.

Cyclosporin and minoxidil promote hair growth.

This study found that tamoxifen citrate markedly inhibited castration-induced diffuse hair growth in castrated female mice, while cyproterone showed only slight inhibition in male mice.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

This study reported the genotypic and allelic frequencies of seven SNPs associated with androgenetic alopecia in Mexican individuals, highlighting significant differences in one SNP between cases and controls in Western Mexico.

In this study, researchers found no significant association between selected CYP19A1 and ESR2 gene SNPs and female androgenetic alopecia in the Polish population studied.

This study developed a transgenic mouse model to explore androgenetic alopecia, finding that inducible COX2 expression led to sebaceous gland changes and hair miniaturization, with reversible effects upon reducing COX2.

This study identified significant differences in cytokine levels between people with primary cicatricial alopecias and unaffected individuals, suggesting cytokines may play a role in the condition's autoimmune nature and management.